Skip to main content

Advertisement

Table 2 Altered chromosomal regions showing significant differences between lesions with HPV31 compared to those with HPV16 (FDR < 0.2).

From: HPV type-related chromosomal profiles in high-grade cervical intraepithelial neoplasia

   Number of CIN2/3 cases loss vs. no loss    
Region Cytoband HPV16 loss HPV31 loss FDR HPV16 gain HPV31 gain
chr2:222405165-227437895 2q36.1-q36.3 0 3 0.123 0 0
chr2:229728860-238929377 2q36.3-q37.3 0 3 0.123 0 0
chr4:49276564-62563622 4p11-q13.1 0 3 0.132 1 0
chr4:71160319-78914719 4q13.3-q21.1 0 3 0.132 1 0
chr4:79281456-84030000 4q21.21-q21.22 0 3 0.132 1 0
chr4:88363994-132792857 4q21.3-q28.3 0 3 0.132 1 0
chr4:133037098-163174205 4q28.3-q32.2 0 3 0.132 1 0
chr4:163304315-191027815 4q32.2-q35.2 0 3 0.132 1 0
chr6:431607-3540777 6p25.3-p25.2 0 3 0.121 1 0
chr6:7902624-26085970 6p24.3-p22.2 0 3 0.121 0 0
chr6:27956910-31362796 6p22.1-p21.33 0 3 0.121 0 0
chr6:32718990-36975126 6p21.32-p21.2 0 3 0.121 0 0
chr6:42755363-48175246 6p21.1-p12.3 0 3 0.121 0 0
chr6:48648135-106496239 6p12.3-q21 0 3 0.121 0 0
chr6:107106382-169915340 6q21-q27 0 3 0.121 0 0
chr8:142600766-145818157 8q24.3 0 3 0.127 5 3
chr17:3564934-7259932 17p13.2-p13.1 0 3 0.122 0 0
chr17:7328200-10781444 17p13.1-p12 0 3 0.122 0 0
chr17:12531028-22078641 17p12-p11.2 0 3 0.122 0 0
   Number of CIN2/3 cases gain vs. no gain    
Region Cytoband HPV16gain HPV31gain FDR HPV16loss HPV31loss
chr1:107415557-114310216 1p13.3-p13.2 3 7 0.163 0 0
chr1:114666834-146812099 1p13.2-q21.2 3 7 0.163 0 0
chr1:148081768-151210846 1q21.2-q21.3 3 7 0.163 0 0
chr1:151380037-167624107 1q21.3-q24.3 3 7 0.163 0 0
chr1:168079451-172935386 1q24.3-q25.2 3 7 0.163 0 0
chr1:172950731-177727312 1q25.2-q25.3 2 7 0.063 0 0
chr1:177742624-194855793 1q25.3-q31.3 2 8 0.029 0 0
chr1:195212008-208655399 1q31.3-q32.3 2 8 0.029 0 0
chr1:212426726-217520338 1q41 2 8 0.029 0 0
chr1:218155880-223642833 1q41-q42.13 2 8 0.029 0 0
chr1:223683098-230121747 1q42.13-q42.2 2 7 0.063 0 0
chr1:231048153-234780716 1q42.3-q43 2 7 0.063 0 0
chr1:236021319-242608344 1q43-q44 2 8 0.029 0 0
chr1:242848259-246751472 1q44 2 8 0.029 0 0
  1. All lesions included in the analysis had > 1.5% aberrations